Deep Brain Stimulation and the Neuroethics of Responsible Publishing: When One Is Not Enough

 In 2004, the International Committee of Medical Journal Editors put forward a fundamental truth: "The case against selective reporting is particularly compelling for research that tests interventions that could enter mainstream clinical practice."1 There is perhaps no arena in medical research where the threat of selective reporting is greater than in the emerging field of deep brain stimulation (DBS) and neuromodulation.